HCB News: And I know that from our conversations in the past that point of care is a priority for you, especially as an emergency room physician. Is there a wireless connection between the headband and the control module? And how does Ceribell’s system indicate that there are non-convulsive seizures?
Those are great questions. Right now our headband is connected with a wire to the recorder, but remember that recorder is right adjacent to the patient. The other thing which is quite unique to Ceribell is our AI algorithm, which is continuously analyzing EEG signals in the background. It is set at different thresholds to send an alarm to the bedside nurse or physician, as sort of an early warning system. When you're having a seizure, it's more or less like your brain is on fire, and you want to put that fire out as quickly as possible. Ceribell is your smoke alarm. When its alarm goes off, everyone treating a patient knows that something serious is going on, and can take care of it quickly. And that ultimately leads to better patient outcomes.
HCB News: We understand that you’ve enjoyed a fairly robust adoption curve. Tell us more about that trajectory.
We're FDA approved, commercially available, and have quickly been adopted in over 200 hospitals in the United States. These include academic centers such as Stanford, Yale, the University of New Mexico, and UCLA as well as other large IDNs such as HCA and Kaiser. And they've all vetted the technology and recognize it's going to have a big role in their patient care.
HCB News: That’s rapid adoption given that, in general, new devices tend to take a while to be adopted—I’m thinking of the need for education, changes in habits, budgeting, and the like. What’s your thinking about the future?
I see what Ceribell has developed becoming a new standard of care. And there's a strong precedent for that if you look at other non-invasive monitoring, whether it's EKG monitoring, pulse oximetry, end-tidal CO2, or non-invasive hemodynamics, which have all become standard of care for seriously ill patients. Brain monitoring, which has been conspicuously absent, finally has an opportunity to be monitored with a simple device. And I believe that by doing that, we're going to be able to detect more neurological conditions, which is ultimately going to help a lot more patients.
Back to HCB News